$1,000 Invested in Tesla 10 Years Ago Is Worth Over $27,000 Today. Can SpaceX Follow That Same Path Over the Next Decade?

The article argues SpaceX (Space Exploration Technologies) may have limited near-term upside because its IPO was priced at a very high valuation, with the possibility of underperforming early similar to other “mega-IPOs.” It notes Tesla already delivered generational gains (about +6,100% over its first decade), while SpaceX would need ~+2,600% over the next decade to match, implying ~39% annual returns—described as difficult. Overall, it recommends not chasing the IPO and instead waiting for “IPO mania” to cool.

Analysis

This is a classic duration-vs-valuation setup: the market is paying today for a bundle of optionality that likely won’t monetize on the same timetable. The key issue is not whether the platform can compound; it is whether launch, broadband, and any AI-infrastructure adjacency deserve one blended multiple. That mix usually earns a conglomerate discount early, because the highest-variance segment drags on the valuation even if one unit prints strong growth.

For competitors, the cleaner public beneficiaries are not the obvious “SpaceX killers,” but the names with narrower stories and easier underwriting: RKLB, ASTS, and to a lesser extent LUNR can look relatively more investable when investors get skeptical of pay-for-future hype. The second-order effect is a rotation away from speculative mega-duration names toward businesses with visible unit economics and less binary capex intensity. If the IPO becomes a retail frenzy, it can also temporarily crowd out capital from other high-beta space/AI proxies.

The near-term risk is that post-listing supply and lock-up dynamics cap upside for months even if sentiment stays positive. What would reverse the bearish view is hard evidence that Starlink is becoming a self-funding cash engine with improving retention/ARPU and that launch cadence is translating into persistent operating leverage, not just top-line growth. Without that, the stock is likely to trade more like an expensive call option than a compounding franchise.

Contrarian view: the consensus may be underestimating how quickly a dominant network business can re-rate once the market sees recurring cash generation. But that is a 6-18 month proof point, not a day-one catalyst, so the burden of proof stays high.

Key Decisions for Investors

• Short SPCX on post-IPO strength or via 1-3 month put spreads if listed options are liquid; thesis is multiple compression from valuation overhang and lock-up supply. Risk/reward is attractive only if initial enthusiasm persists above fundamentals.
• Pair trade: long RKLB / short SPCX for 1-3 months to express preference for a simpler, more legible space monetization story over a bundled, high-duration platform. Falsify if SPCX shows clear recurring FCF acceleration or if RKLB execution slips.
• Set a watchlist alert, not a trade, on Starlink operating metrics and any disclosed cash-flow bridge; if recurring revenue quality proves out over 2 reporting periods, cover shorts and reassess. If not, treat rallies as sellable.
• Avoid chasing TSLA sympathy trades unless the article-driven speculation broadens into actual risk-appetite rotation; the link is narrative, not earnings. No direct fundamental read-through to NVDA/NFLX/NDAQ at this stage.